Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Pei Wen Chao"'
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 6, Pp 1243-1250 (2020)
Debates on whether statin use reduces the effectiveness of influenza vaccines against critical illness and death among persons >65 years of age continue. We conducted a study of 9,427,392 persons >65 years of age who did and did not receive influenza
Externí odkaz:
https://doaj.org/article/6b0653e5063b4639a9caae4e4bf7470d
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210479 (2019)
ObjectivesAnimal and ex vitro studies suggested lipid-lowering agents (LLAs) may be used as an adjunct to standard anti- tuberculosis (TB) treatment. No human study has been conducted to date. Using the Taiwan National Health Insurance Research Datab
Externí odkaz:
https://doaj.org/article/949c14061be84749a200b5cc48cc7acc
The ability to control the expression of a therapeutic gene or a transgene in mammalian cells is crucial for safe and efficacious gene and cell therapy, as well as for elucidating the function of a specific gene product. Yet current mammalian gene re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee81aea9d1a13d46581042974ead7649
https://doi.org/10.1101/2023.01.27.525935
https://doi.org/10.1101/2023.01.27.525935
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 2 (2017)
BackgroundLong‐term cardiovascular outcomes after sepsis in patients with chronic kidney disease are not well known. We aimed to examine the risk of subsequent cardiovascular events in patients with chronic kidney disease discharged after hospitali
Externí odkaz:
https://doaj.org/article/ee8f53fb8b404023bbba78c5577d41a3
Publikováno v:
Surgical Infections. 23:941-942
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9270c668cb6ca713fae1a34d2369187f
https://doi.org/10.1089/sur.2022.239
https://doi.org/10.1089/sur.2022.239
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 6, Pp 1243-1250 (2020)
Emerging Infectious Diseases
Emerging Infectious Diseases
Influenza vaccine effectively reduced risks for in-hospital death or hospitalization, regardless of statin use.
Debates on whether statin use reduces the effectiveness of influenza vaccines against critical illness and death among persons >65 ye
Debates on whether statin use reduces the effectiveness of influenza vaccines against critical illness and death among persons >65 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f557e65a8537a2658265bf7cf5ea4b1a
https://wwwnc.cdc.gov/eid/article/26/6/19-0646_article
https://wwwnc.cdc.gov/eid/article/26/6/19-0646_article
Publikováno v:
Food Hydrocolloids. 130:107722
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d11621b7b655429350d673f15d3d0af0
https://doi.org/10.1016/j.foodhyd.2022.107722
https://doi.org/10.1016/j.foodhyd.2022.107722
Autor:
Pei Wen Chao, Shu-Chen Kuo, Shuo Ming Ou, Yi Jung Lee, Hung Meng Huang, Yung Tai Chen, Chia Hsiang Shih
Publikováno v:
European Journal of Internal Medicine. 54:65-69
Objective The objective of this study is to determine whether vaccination against influenza is associated with a reduced risk of acute kidney injury (AKI) in a nationwide cohort of adults aged ≥65 years. Methods We investigated a total of 13,270 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88fbaedfdde9a2e7c266dfd3d67f55fa
https://doi.org/10.1016/j.ejim.2018.04.020
https://doi.org/10.1016/j.ejim.2018.04.020
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210479 (2019)
PLoS ONE
PLoS ONE
ObjectivesAnimal and ex vitro studies suggested lipid-lowering agents (LLAs) may be used as an adjunct to standard anti- tuberculosis (TB) treatment. No human study has been conducted to date. Using the Taiwan National Health Insurance Research Datab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f797d85314b472b782575a9d37dc8b5
https://doaj.org/article/949c14061be84749a200b5cc48cc7acc
https://doaj.org/article/949c14061be84749a200b5cc48cc7acc
Autor:
Chia Jen Shih, Tzeng Ji Chen, Shuo Ming Ou, Shu-Chen Kuo, Yung Tai Chen, Ching Min Tseng, Hsi Ning Chu, Yi Jung Lee, Pei Wen Chao
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 194:209-217
Rationale: Patients with sepsis who survive to hospital discharge may present with ongoing high morbidity and mortality. However, little is known about the risk of long-term, all-cause mortality and cardiovascular outcomes after sepsis.Objectives: Ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f1f178a59504148a04ec5d2c96e31c9
https://doi.org/10.1164/rccm.201510-2023oc
https://doi.org/10.1164/rccm.201510-2023oc